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OBJECTIVES The goal of this study was to examine the impact of diabetes and prior myocardial infarction
(MI) on mortality in men.
BACKGROUND Previous studies have suggested that a history of diabetes and a prior MI confer similar risk
for subsequent fatal coronary heart disease (CHD). Few studies have examined duration of
diabetes in relation to mortality.
METHODS We examined type 2 diabetes and prior MI in relation to mortality among 51,316 men aged
40 to 75 years in the Health Professionals Follow-up Study.
RESULTS During 10 years of follow-up, we documented 4,150 deaths from all causes, including 1,124
deaths from CHD. Compared with men without diabetes or prior MI at baseline, the
multivariate relative risks (RRs) for fatal CHD were 3.84 (95% confidence interval [CI], 3.12
to 4.71) for those with diabetes only, 7.88 (95% CI, 6.86 to 9.05) for those with MI only, and
13.41 (95% CI, 10.49 to 17.16) for those with both diabetes and MI. The corresponding RRs
for total mortality were 1.91 (95% CI, 1.70 to 2.15), 2.23 (95% CI, 2.03 to 2.45), and 3.13
(95% CI, 2.56 to 3.84), respectively. Duration of diabetes was an independent risk factor for
total as well as CHD mortality; the multivariate RRs of CHD mortality for increasing
duration of diabetes (5 years, 6 to 10 years, 11 to 15 years, 16 to 25 years, 26 years) were
1.63, 1.93, 2.35, 2.31, and 3.87, respectively (p for trend0.001), compared with nondiabetic
participants.
CONCLUSIONS These findings support that both diabetes and MI are associated with elevated total and CHD
mortality, and having both conditions is particularly hazardous. Longer duration of diabetes
is a strong predictor of death among diabetic men. (J Am Coll Cardiol 2002;40:954–60)
© 2002 by the American College of Cardiology Foundation
The prevalence of type 2 (noninsulin-dependent) diabetes
mellitus has been rising in the U.S. and worldwide due to
increasing obesity and decreasing physical activity (1). It is
expected that 21.9 million of adults will have diabetes in the
U.S. in year 2025 (2). Coronary heart disease (CHD) is a
leading cause of death among people with type 2 diabetes.
Previous epidemiologic studies have reported about two- to
threefold increased risk of CHD mortality associated with
diabetes for men (3) and even greater relative risks among
women (4,5).
Recent data suggest that diabetes and prior CHD confer
similar risk for fatal CHD (6,7). In the Physicians’ Health
Study, a prior CHD appeared to be associated with a greater
risk of CHD mortality than diabetes in men (8), but that
study did not examine duration of diabetes. Therefore, we
compared the impact of diabetes and prior myocardial
infarction (MI) on total and CHD mortality in men in the
Health Professionals Follow-up Study (HPFS). We also
evaluated the association between duration of diabetes and
mortality.
METHODS
Study population. The HPFS was established in 1986
with the enrollment of 51,529 male health professionals 40
to 75 years of age (9). The HPFS cohort consists primarily
of dentists and veterinarians but also includes pharmacists,
optometrists, osteopathic physicians, and podiatrists. About
86% of participants were working full-time or part-time at
baseline, and about 96% of participants were white. Mem-
bers of the cohort have reported information on various
lifestyle factors including smoking, weight, physical activity,
vitamin E supplement use, diagnoses of major conditions,
and history of high blood cholesterol and hypertension
biennially since their enrollment. Alcohol intake was re-
ported in 1986, 1990, and 1994 using a semiquantitative
food-frequency questionnaire. Family history of MI before
60 years of age and height were reported at baseline.
Follow-up rates have averaged 94% for each two-year cycle.
For the current analysis, we excluded men who reported
a diagnosis of type 1 diabetes (n  101) and those who
reported having diabetes diagnosed before turning 30 (n 
57). A total of 51,316 men were included in the analysis.
The study was approved by the Human Research Com-
mittees at the Harvard School of Public Health.
Documentation of diabetes and MI. The 1986 baseline
questionnaire inquired about a history of physician-
diagnosed diabetes mellitus. Biennial questionnaires mailed
From the *Channing Laboratory, Department of Medicine, Harvard Medical
School and Brigham and Women’s Hospital; and the Departments of †Nutrition and
‡Epidemiology, Harvard School of Public Health, Boston, Massachusetts. Supported
by research grants CA55075 and HL35464 from the National Institutes of Health.
Dr. Hu’s work is supported by an American Diabetes Association Research Award.
Manuscript received December 4, 2001; revised manuscript received May 7, 2002,
accepted May 24, 2002.
Journal of the American College of Cardiology Vol. 40, No. 5, 2002
© 2002 by the American College of Cardiology Foundation ISSN 0735-1097/02/$22.00
Published by Elsevier Science Inc. PII S0735-1097(02)02044-2
between 1988 and 1996 were used to identify newly diag-
nosed cases of diabetes. To confirm self-reports of diag-
nosed diabetes, a supplementary questionnaire was mailed
to men reporting the diagnosis. Men were considered to
have confirmed type 2 diabetes if any of the following
criteria were met: 1) one or more classical symptoms
(excessive thirst, polyuria, unexplained weight loss, hunger,
or pruritus) plus a fasting plasma glucose level of 140
mg/dl (7.8 mmol/l) or a random plasma glucose level of
200 mg/dl (11.1 mmol/l); 2) at least two elevated plasma
glucose concentrations on different occasions (a fasting level
of 140 mg/dl or a random level of 200 mg/dl and/or a
concentration of 200 mg/dl after 2 h of oral glucose
tolerance testing) in the absence of symptoms; or 3) treat-
ment with hypoglycemic medications (insulin or oral hypo-
glycemic agents). We used the National Diabetes Data
Group criteria (10) because the analytic cohort preceded the
publication of the American Diabetes Association guideline
in 1997 (11).
The validity of self-reported type 2 diabetes was docu-
mented in a subsample of 71 men from the HPFS. A
physician blinded to the information reported on the sup-
plementary questionnaire reviewed the medical records ac-
cording to the diagnostic criteria. Of the 71 patients, 12 had
incomplete records, for example, absent laboratory data
(n  2) or incomplete laboratory data (n  9). Among the
remaining 59 cases, the diagnosis of type 2 diabetes was
confirmed in 57 (97%). One patient denied the diagnosis,
and another lacked evidence of diabetes in his submitted
records. In the primary analyses, we used self-reported
diabetes status. In a secondary analysis, we used only the
confirmed diabetic cases.
Diagnosis of MI was also reported through question-
naires. We used self-reported information in the analysis.
Validation studies among female nurses (12) and male
physicians (13) have shown reliable reporting of CHD
events compared with medical record reviews.
Ascertainment of death. Deaths were documented by
responses to follow-up questionnaires by family members or
the postal service and by a search of the National Death
Index. Participants who did not respond were assumed to be
alive if they were not listed in the National Death Index. If
a death from cancer or cardiovascular disease (CVD) was
identified, we sought medical records to confirm the cause
of death. We obtained death certificates for deaths whose
cause was not confirmed by other sources. Cause of death
was decided on the basis of all available information,
including death certificates, medical records, and autopsy
results. We classified deaths as being due to CHD (Inter-
national Classification of Diseases, Ninth Revision, codes
410-414), CVD (codes 390-459, 795), or all other causes.
Statistical analysis. We calculated mortality according to
the history of diabetes and CHD at baseline as well as the
diagnoses updated every questionnaire cycle during follow-
up. Participants contributed person-time from the date of
return of the 1986 questionnaire until the date of death or
January 31, 1996, whichever came first. The relative risk of
death was calculated as the rate for a given category of
diabetes and CHD status as compared with the rate for the
referent category of no diabetes and no CHD. Duration of
clinical diabetes was calculated as years since first diagnosis
of diabetes. The variable was updated every questionnaire
cycle and was divided into five categories (5 years, 6 to 10
years, 11 to 15 years, 16 to 25 years, 26 years). For the
analysis of duration of diabetes, we used nondiabetic par-
ticipants as the reference. We employed Cox proportional
hazards regression (14) in analyses. To control as finely as
possible for confounding by age, calendar time, and any
possible two-way interactions between these two time
scales, we stratified the analysis jointly by age in months at
start of follow-up and calendar year of the current question-
naire cycle. The time scale for the analysis was then
measured as months since the start of the current question-
naire cycle, which was equivalent to age in months because
of the way we structured the data and formulated the model
for analysis. Multivariate models adjusted for smoking
status, body mass index, physical activity, parental history of
MI before age 60 years, alcohol intake, and vitamin E
supplement use, simultaneously. The SAS PHREG proce-
dure (SAS Institute, Cary North Carolina) was used for all
analysis, and the Anderson-Gill data structure (15) was used
to handle time-varying covariates efficiently, where a new
data record was created for every questionnaire cycle at
which a participant was at risk, with covariates set to their
values at the time that the questionnaire was returned. All
covariates except parental history of MI were updated in
each questionnaire cycle. For all relative risks, 95% confi-
dence intervals (CIs) were calculated. Tests for trend were
conducted using the median value for each category of
duration of diabetes as a continuous variable. All p values
were two-sided.
RESULTS
During 387,188 person-years of follow-up of 51,316 men,
we documented 4,150 deaths (1,471 CVD deaths, 1,124
CHD deaths). Table 1 shows the characteristics of men
according to the categories of diabetes and MI at baseline.
In this cohort of men, 2.5% had only diabetes, 4.0% had
only a prior MI, and 0.4% had both diabetes and MI at
baseline. Men with MI and no diabetes were more likely to
be smokers. The history of hypertension and hypercholes-
terolemia was more frequent among those with both diabe-
tes and MI. Men in this group were also older, less active,
Abbreviations and Acronyms
CHD  coronary heart disease
CI  confidence interval
CVD  cardiovascular disease
HPFS  Health Professionals Follow-up Study
MI  myocardial infarction
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and less likely to use multivitamins or vitamin E supple-
ments.
Table 2 presents the relative risk of death due to all causes
as well as due to CVD and CHD according to the history
of diabetes and MI at baseline. Participants with diabetes
only had a slightly lower risk of death due to all causes than
those with MI only. Men with both conditions had a
relative risk of 3.13 (95% CI, 2.56 to 3.84) compared with
those without diabetes and MI. For CVD or CHD deaths,
again, having either diabetes or MI conferred an elevated
risk. In addition, having only a prior MI conferred much
higher risk of death than having diabetes only. The associ-
ations were similar when we used confirmed diabetes status;
the relative risks of CHD death were 3.67 (95% CI, 2.84 to
Table 1. Age-Standardized Distribution of Potential Coronary Risk Factors According to
History of Diabetes and CHD in the Health Professionals Follow-Up Study in 1986*
Disease Status
No Diabetes
No CHD
Diabetes
No CHD
CHD
No Diabetes
Diabetes
and CHD
No. of men 47,763 1,285 2,038 230
% of group
Current smokers 10 10 13 6
History of hypertension 21 44 38 61
History of hypercholesterolemia 11 24 41 56
Insulin use — 19 — 15
Oral hypoglycemic medication — 31 — 30
Parental history of MI before 60 years of age 12 14 30 26
Multivitamin use 42 40 37 32
Vitamin E supplement use 19 18 19 15
Working full/part time 87 87 81 82
White 96 91 96 92
Mean
Age (yrs) 54 61 63 64
Alcohol (g/day) 12 8 11 7
Body mass index (kg/m2) 25 26 26 27
Physical activity (METs/wk) 20 16 18 14
Dietary fiber (g/day) 21 23 23 24
Saturated fat (g/day) 24 25 21 23
Polyunsaturated fat (g/day) 13 14 13 14
Trans fat (g/day) 2.8 2.7 2.6 2.7
Dietary cholesterol (mg/day) 303 344 271 291
*Except for the data on mean age, all data shown are standardized to the age distributions of the cohort in 1986.
CHD  coronary heart disease, METs  metabolic equivalents, MI  myocardial infarction.
Table 2. Relative Risks and 95% CIs of Death From All Causes, Cardiovascular Disease, and
CHD According to History of Diabetes and a Prior CHD at Baseline in 1986 in the Health
Professionals Follow-Up Study 1986–1996*
Disease Status
No Diabetes
No CHD
Diabetes
No CHD
CHD
No Diabetes
Diabetes
and CHD
Deaths from all causes
No. of cases 3,195 312 545 98
Age-adjusted RR (95% CI) 1.0 2.43 (2.16–2.73) 2.44 (2.22–2.67) 4.17 (3.41–5.10)
Multivariate RR (95% CI) 1.0 1.91 (1.70–2.15) 2.23 (2.03–2.45) 3.13 (2.56–3.84)
All cardiovascular deaths
No. of cases 848 149 392 82
Age-adjusted RR (95% CI) 1.0 4.22 (3.54–5.04) 6.36 (5.63–7.20) 12.87 (10.23–17.19)
Multivariate RR (95% CI) 1.0 3.34 (2.80–3.99) 5.63 (4.97–6.39) 9.41 (7.45–11.88)
Fatal CHD
No. of cases 570 113 364 77
Age-adjusted RR (95% CI) 1.0 4.82 (3.93–5.91) 8.95 (7.81–10.25) 18.12 (14.23–23.08)
Multivariate RR (95% CI) 1.0 3.84 (3.12–4.71) 7.88 (6.86–9.05) 13.41 (10.49–17.16)
*Adjusted for age (continuous), smoking (never, past, current14, 15–24, 25 cigarettes/day), body mass index (23, 23–24.9,
25–29.9, 30–34.9, 35 kg/m2), physical activity (3.9, 3.9–10.8, 10.9–21.4, 21.5–40.0, 40.1 metabolic equivalents/wk),
alcohol intake (nondrinker, 5, 5–29, 30 g/day), family history of myocardial infarction (yes, no), and vitamin E supplement
use (yes, no).
CHD  coronary heart disease; CI  confidence interval; RR  relative risk.
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4.75) for those with diabetes only (n  67) and 11.03 (95%
CI, 7.58 to 16.05) for those with both diabetes and MI (n
30).
We then updated the status of diabetes and MI every two
years during follow-up. A total of 230 men had both
diabetes and MI at baseline, but the number was increased
to 746 using updated information. Similarly, the number of
diabetic men without MI was increased from 1,285 to
2,428. The number of nondiabetic men with prior MI
changed from 2,038 to 3,652 using updated information.
This update also resulted in assigning about twice as many
deaths to the category with both diabetes and MI (Table 3),
in part because many of the diabetic patients at baseline
developed nonfatal MI during follow-up. The overall find-
ings were similar to those using baseline information (Table
2). The mortality risk was slightly attenuated for those with
diabetes only when we used updated data, probably reflect-
ing the inclusion of many newly diagnosed diabetic patients
with shorter duration.
Among diabetic men duration of diabetes was monoton-
ically associated with total mortality (Table 4). Compared
with nondiabetic men, those with diabetes diagnosis 5
years had a relative risk of 1.48 (95% CI, 1.27 to 1.72), and
those with diagnosis more than 26 years had a relative risk
of 1.91 (95% CI, 1.43 to 2.55). A stronger association was
found for death from CHD; the relative risk for those with
diabetes diagnosis more than 26 years was 3.87 (95% CI,
2.64 to 5.67) compared with nondiabetic men. Adjusting
for history of high blood cholesterol and hypertension did
not materially alter the overall associations.
We also examined duration of diabetes and CHD deaths
stratified by history of MI (Fig. 1). Duration of diabetes was
linearly associated with increased CHD mortality indepen-
dent of MI status. Compared with men without diabetes or
MI, those with prior MI and diabetes longer than 26 years
had the relative risk of 21.08 (95% CI, 12.42 to 35.78).
We examined whether the associations between existing
diabetes and prior MI and mortality were modified by other
potential risk factors (Table 5). For these analyses we used
updated diabetes and MI status and also updated the
stratification variables every two years when such data were
available. The risk of death due to diabetes or MI was
higher in the younger age group than the older group. In
men with both diabetes and MI, the relative risks of death
due to all causes were 6.10 (95% CI, 3.56 to 10.44) for men
60 years and 2.41 (95% CI, 1.98 to 2.94) for those 70
Table 3. Relative Risks and 95% CIs of Death From All Causes, Cardiovascular Disease, and
CHD According to the Status of Diabetes and CHD at Baseline and During Follow-Up in the
Health Professionals Follow-Up Study 1986–1996*
Disease Status
No Diabetes
No CHD
Diabetes
No CHD
CHD
No Diabetes
Diabetes
and CHD
Deaths from all causes
No. of cases 2.867 375 697 211
Age-adjusted RR (95% CI) 1.0 2.10 (1.88–2.34) 2.15 (1.98–2.34) 3.85 (3.35–4.44)
Multivariate RR (95% CI) 1.0 1.76 (1.58–1.96) 2.07 (1.90–2.25) 3.12 (2.71–3.60)
All cardiovascular deaths
No. of cases 699 145 467 160
Age-adjusted RR (95% CI) 1.0 3.35 (2.79–4.01) 5.94 (5.27–6.71) 12.29 (10.31–14.65)
Multivariate RR (95% CI) 1.0 2.75 (2.29–3.30) 5.51 (4.88–6.23) 9.64 (8.06–11.53)
Fatal CHD
No. of cases 440 108 432 144
Age-adjusted RR (95% CI) 1.0 4.08 (3.30–5.04) 9.08 (7.91–10.43) 18.43 (15.19–22.36)
Multivariate RR (95% CI) 1.0 3.37 (2.72–4.17) 8.39 (7.29–9.65) 14.51 (11.91–17.67)
*The diagnoses of diabetes and CHD were updated every two years. Adjusting for the same covariates as Table 2.
CHD  coronary heart disease; CI  confidence interval; RR  relative risk.
Table 4. Relative Risks and 95% CIs of Death From All Causes and CHD According to Duration of Diabetes in the Health
Professionals Follow-Up Study 1986–1996*
No
Diabetes
Duration of Diabetes
p for
Trend<5 Years 6–10 Years 11–15 Years 16–25 Years 26 Years
Deaths from all causes
No. of cases 3,564 180 82 54 84 47
Age-adjusted RR (95% CI) 1.0 1.72 (1.48–2.00) 1.90 (1.52–2.37) 2.18 (1.67–2.86) 2.32 (1.87–2.88) 2.56 (1.93–3.44)  0.001
Multivariate RR (95% CI) 1.0 1.48 (1.27–1.72) 1.58 (1.27–1.97) 1.71 (1.31–2.24) 1.85 (1.48–2.30) 1.91 (1.43–2.55)  0.001
Deaths from CHD
No. of cases 872 62 30 23 35 29
Age-adjusted RR (95% CI) 1.0 2.45 (1.89–3.18) 2.75 (1.91–3.97) 3.66 (2.41–5.54) 3.72 (2.65–5.23) 6.38 (4.39–9.27)  0.001
Multivariate RR (95% CI) 1.0 1.63 (1.25–2.11) 1.93 (1.34–2.79) 2.35 (1.54–3.58) 2.31 (1.64–3.25) 3.87 (2.64–5.67)  0.001
*Adjusted for the same variables as in Table 2 as well as history of CHD.
CHD  coronary heart disease; CI  confidence interval; RR  relative risk.
957JACC Vol. 40, No. 5, 2002 Cho et al.
September 4, 2002:954–60 Impact of Diabetes and MI on Mortality
years. The increased CHD mortality associated with having
both diabetes and MI was more striking; the relative risks
were 33.66 (95% CI, 17.26 to 65.65) for men60 years and
9.50 (95% CI, 7.19 to 12.56) for those 70 years.
Prior diabetes or CHD conferred higher relative risks of
death due to CHD among those without hypertension than
those with hypertension (Table 5). The positive associations
were also stronger in men without history of high blood
cholesterol.
DISCUSSION
Summary of findings. This prospective study provides
further evidence that diabetes, especially of long duration, is
a powerful predictor of elevated risk of total and CHD
mortality in men, although the magnitude for CHD mor-
tality is smaller than that associated with prior MI. Indi-
viduals with both diabetes and prior MI were at particularly
high risk.
Our findings support current guidelines that recommend
aggressive management of cardiovascular risk factors includ-
ing hypertension, dyslipidemia, and lifestyle factors (smok-
ing, obesity, and diet) in diabetic patients. Recent guidelines
from the American Diabetes Association (16) and National
Cholesterol Education Program (17) also recommend the
same cholesterol-lowering goal for people with diabetes and
no clinical CHD as for those with pre-existing CHD.
Review of other epidemiologic studies. Several recent
studies have compared the impact of diabetes and prior
CHD on total and CHD mortality. A Finnish study, which
combined both men and women, reported that CHD
mortality among subjects with diabetes but no CHD was
not significantly different from those with CHD but no
diabetes (6). In the Nurses’ Health Study of women, the
impacts of diabetes and prior CHD were similar for total
and CHD mortality (7). Our results in men were in accord
with the Physicians Health Study which found that the
magnitude of excess risk conferred by diabetes was similar to
that conferred by prior CHD for all-cause mortality but
weaker for CHD mortality in men (8).
Few studies have evaluated duration of diabetes in rela-
tion to CHD mortality. The Whitehall Study with 15 years
of follow-up of men did not find any increase of mortality
with increasing duration of diabetes (18). However, there
were only 47 deaths among diabetic patients with known
duration of diabetes. The London Cohort of the WHO
Multinational Study of Vascular Disease in Diabetics also
did not find any association between duration of type 2
diabetes and CVD mortality among 246 diabetic patients
(19). Lack of statistical power might be an explanation for
these null findings. The Nurses’ Health Study found a linear
association between duration of diabetes and total as well as
CHD mortality in women (7). Our results in men also
indicated increased total and CHD mortality with increas-
ing duration of diabetes.
Strengths and limitations. Our study provided a unique
opportunity to evaluate diabetes and CHD in relation to
mortality using baseline as well as updated disease status
with a large sample size and relatively long duration of
Figure 1. Duration of diabetes and death from coronary heart disease (CHD) by CHD history in the Health Professionals Follow-up Study 1986 to 1996.
White bars  those without a history of CHD; black bars  those with a history of CHD.
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follow-up. The follow-up rate in this cohort was high. We
had detailed information on various cardiovascular risk
factors and adjusted for them in multivariate analyses.
Several limitations need to be considered. First, diagnosis
of diabetes and CHD were self-reported. Although studies
have indicated that self-reporting of these medical condi-
tions are reliable, some misclassification is inevitable. Sec-
ond, our nondiabetic participants were not uniformly
screened for glucose intolerance and may include a few
subclinical cases of diabetes. However, we believe that the
proportion of undiagnosed diabetes in our cohort of health
professionals is small relative to the general population due
to their education and access to health care. Third, the
reported duration of diabetes might be underestimated
because the actual onset of diabetes frequently precedes
clinical diagnosis by several years. However, these possibil-
ities would have attenuated the association between
diabetes and mortality and led to underestimates of the
risk in the diabetic population. Fourth, the reference
group of participants without diabetes or CHD will
include those with impaired glucose tolerance, a precur-
sor of diabetes, which also increases total as well as CVD
mortality (20). If these people with impaired glucose
tolerance were excluded from the reference, the excess
risk related to either diabetes or CHD would have been
even greater. Finally, because the vast majority of our
participants were white, our findings may not be gener-
alized to other racial groups.
In our analysis we used the National Diabetes Data
Group criteria (10) because all of the diabetic patients were
diagnosed before 1996, before the release of new criteria
from the American Diabetes Association (11). Thus, the
participants without diabetes will include some diabetic
cases based on current criteria. However, again, assigning
the cases to diabetic groups would likely make the results
stronger.
Conclusions. In this population of men, both a prior MI
and diabetes elevated risk of total and CHD mortality
substantially. A combination of diabetes and MI is associ-
ated with dramatically increased risk of total and CHD
mortality. Increasing duration of diabetes is associated with
increased risk of total and CHD mortality.
Table 5. Multivariate Relative Risks* and 95% Confidence Intervals of Death From All Causes
and CHD According to the Status of Diabetes and CHD at Baseline and During Follow-Up in
the Health Professionals Follow-Up Study 1986–1996: Subgroup Analysis
Disease Status
No Diabetes
No CHD
Diabetes
No CHD
CHD
No Diabetes
Diabetes
and CHD
Death From All Causes
Age
60 (n  688) 1.0 2.79 (2.05–3.80) 3.16 (2.39–4.18) 6.10 (3.56–10.44)
60–69 (n  1,440) 1.0 1.79 (1.49–2.16) 2.54 (2.21–2.93) 4.18 (3.34–5.23)
70 (n  2,022) 1.0 1.55 (1.33–1.79) 1.69 (1.51–1.90) 2.41 (1.98–2.94)
Hypertension
No (n  2,184) 1.0 1.87 (1.57–2.23) 2.24 (1.98–2.53) 3.68 (2.82–4.81)
Yes (n  1,966) 1.0 1.51 (1.31–1.75) 1.80 (1.59–2.03) 2.62 (2.20–3.11)
High blood cholesterol
No (n  2,790) 1.0 1.74 (1.52–1.99) 2.11 (1.88–2.38) 3.43 (2.76–4.25)
Yes (n  1,360) 1.0 1.83 (1.51–2.21) 2.12 (1.86–2.41) 3.15 (2.59–3.85)
Family history of MI
No (n  3,602) 1.0 1.71 (1.52–1.92) 2.01 (1.83–2.21) 2.97 (2.53–3.49)
Yes (n  548) 1.0 2.10 (1.51–2.91) 2.35 (1.91–2.88) 3.96 (2.84–5.51)
Death From CHD
Age
60 (n  141) 1.0 6.16 (3.37–11.28) 18.37 (12.36–27.36) 33.66 (17.26–65.65)
60–69 (n  406) 1.0 3.50 (2.45–4.99) 9.52 (7.56–11.99) 20.46 (15.11–27.71)
70 (n  577) 1.0 2.68 (1.99–3.61) 6.26 (5.19–7.56) 9.50 (7.19–12.56)
Hypertension
No (n  452) 1.0 4.13 (2.86–5.96) 11.84 (9.55–14.67) 23.12 (16.08–33.26)
Yes (n  672) 1.0 2.36 (1.81–3.07) 5.76 (4.79–6.91) 9.05 (7.13–11.48)
High blood cholesterol
No (n  607) 1.0 3.59 (2.73–4.71) 9.03 (7.45–10.94) 16.96 (12.62–22.79)
Yes (n  517) 1.0 2.79 (1.97–3.96) 6.71 (5.43–8.29) 10.70 (8.10–14.15)
Family history of MI
No (n  916) 1.0 3.24 (2.56–4.09) 8.51 (7.30–9.92) 14.06 (11.25–17.57)
Yes (n  208) 1.0 4.14 (2.38–7.23) 8.20 (5.82–11.57) 16.95 (10.82–26.54)
*Adjusted for the same variables as in Table 2.
CHD  coronary heart disease; MI  myocardial infarction.
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